Silence Therapeutics welcomes new board member
Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…
Pharmaceuticals, Biotechnology and Life Sciences
Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…
Study demonstrates the IONA test can accurately predict the presence of the trisomies 21, 18, and 13. Being user-friendly, cost effective and CE-marked will overcome some of the limitations of existing commercial technologies to facilitate implementation in local laboratories.
Horizon Pharma about Express Scripts’ business practices: “Express Scripts… also operates its own mail-order pharmacy and thus is a direct competitor of small, independent specialty pharmacies”
Horizon Pharma on Wednesday announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE).
Anavex has confirmed the information about positive safety and cognitive efficacy data from the Phase 2a Alzheimer’s trial for ANAVEX 2-73.
4D pharma has obtained regulatory and ethical approval for a phase 1 clinical trial in respect of Thetanix.
Biofrontera has announced that there have been no new operational developments or matters which have arisen in relation to the ongoing approval processes or other operational aspects of the Company.
Long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease.
Well-matched influenza vaccine prevents P&I hospitalizations and mortality in NH residents.